Skip to main content

Table 4 Sex, cardiovascular disease (CVD) status and positive attitudes associated with participation in clinical trials

From: Sex and cardiovascular disease status differences in attitudes and willingness to participate in clinical research studies/clinical trials

 

Relative risk (95% CI)

 

Relative risk (95% CI)

 

Attitudea

Women

Men

P value

Non-CVD

CVD

P value

Random

1 [Reference]

0.98 (0.88–1.10)

.79

1 [Reference]

1.03 (0.92–1.16)

.58

Blinded

1 [Reference]

0.99 (0.89–1.20)

.85

1 [Reference]

1.05 (0.94–1.17)

.35

Side effects

1 [Reference]

1.02 (0.79–1.32)

.87

1 [Reference]

0.81 (0.63–1.05)

.11

Conflict of interest

1 [Reference]

1.00 (0.74–1.36)

.99

1 [Reference]

0.92 (0.67–1.25)

.57

Guinea pigs (reversed) b

1 [Reference]

0.84 (0.73–0.98)

.02

1 [Reference]

1.02 (0.88–1.84)

.79

Talking to physician

1 [Reference]

0.95 (0.87–1.04)

.25

1 [Reference]

1.00 (0.91–1.09)

.92

Terminally ill (reversed)b

1 [Reference]

0.93 (0.86–1.00)

.05

1 [Reference]

0.98 (0.91–1.05)

.57

Experimental treatments

1 [Reference]

0.85 (0.61–1.19)

.35

1 [Reference]

0.84 (0.59–1.19)

.33

  1. aAdjusted for age, marital status, race, education, income and current health status
  2. bDisagreement with questionnaire prompt
Back to article page

Trials

ISSN: 1745-6215